Moneycontrol PRO

business

Buy Amrutanjan Health, target price of Rs 300: SBI Cap Sec

In an interview to CNBC-TV18, Sagarika Mukherjee, Senior Research Analyst at SBI Cap Securities, said the company is on a new growth trajectory, which will propel its earnings.

first published: Sep 5, 2014 03:17 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347